1-4 of 4
Judith Lind
Close
Sort by
Journal Articles

Delineating CDK9- Regulated Molecular Events for the Development of Rationally Derived Multiple Myeloma Treatment Strategies

Osman Aksoy, Klaus Podar, Sonia Vallet, Judith Lind, Vincent Sunder-Plassmann, Martin Pecherstorfer
Journal: Blood
Blood (2022) 140 (Supplement 1): 12478–12479.
https://doi.org/10.1182/blood-2022-169914
Published: 2022
Journal Articles

Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs Inducing Synergistic Anti-Myeloma Activity

Judith Lind, Sonia Vallet, Karoline Kollmann, Osman Aksoy, Vincent Sunder-Plassmann, Fengjuan Fan, Elisabeth Zwickl-Traxler, Dagmar Stoiber, Latifa Bakiri, Erwin F Wagner, Martin Sattler, Martin Percherstorfer, Klaus Podar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2644.
https://doi.org/10.1182/blood-2021-145001
Published: 2021
Journal Articles

Delineating CDK9 Regulated Molecular Events for the Development of Rationally Derived Multiple Myeloma Treatment Strategies

Osman Aksoy, Judith Lind, Vincent Sunder-Plassmann, Martin Percherstorfer, Sonia Vallet, Klaus Podar
Journal: Blood
Blood (2021) 138 (Supplement 1): 1598.
https://doi.org/10.1182/blood-2021-149254
Published: 2021
Journal Articles

Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs for Multiple Myelioma Therapy

Judith Lind, PhD, Felix Czernilofsky, Sonia Vallet, MD, Fengjuan Fan, PhD, Martin Sattler, PhD, Latifa Bakiri, Erwin F Wagner, PhD, Martin Percherstorfer, MD, Klaus Podar, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4415.
https://doi.org/10.1182/blood-2019-125202
Published: 2019